APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sphingosine-1-Receptor Modulators Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sphingosine-1-Receptor Modulators Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17403738032 January 2026189 pages

Choose your research edition.

Industry ResearchSphingosine-1-Receptor Modulators Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sphingosine-1-Receptor Modulators Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Sphingosine-1-Receptor Modulators Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sphingosine-1-Receptor Modulators Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Sphingosine-1-Receptor Modulators Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Sphingosine-1-Receptor Modulators Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sphingosine-1-Receptor Modulators Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sphingosine-1-Receptor Modulators Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sphingosine-1-Receptor Modulators Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sphingosine-1-Receptor Modulators Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sphingosine-1-Receptor Modulators Drugs include Sun Pharma, Johnson & Johnson, Novartis, Idorsia, HEC Pharm Co. Limited, Bristol-Myers Squibb, Biocon and Arena Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sphingosine-1-Receptor Modulators Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sphingosine-1-Receptor Modulators Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sphingosine-1-Receptor Modulators Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sphingosine-1-Receptor Modulators Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Sphingosine-1-Receptor Modulators Drugs Segment by Company

Sun Pharma

Johnson & Johnson

Novartis

Idorsia

HEC Pharm Co. Limited

Bristol-Myers Squibb

Biocon

Arena Pharmaceuticals

Sphingosine-1-Receptor Modulators Drugs Segment by Type

Siponimod

Fingolimod

Ozanimod

Other

Sphingosine-1-Receptor Modulators Drugs Segment by Application

Hospital

Clinic

Other

Sphingosine-1-Receptor Modulators Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sphingosine-1-Receptor Modulators Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sphingosine-1-Receptor Modulators Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sphingosine-1-Receptor Modulators Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sphingosine-1-Receptor Modulators Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sphingosine-1-Receptor Modulators Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sphingosine-1-Receptor Modulators Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sphingosine-1-Receptor Modulators Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sphingosine-1-Receptor Modulators Drugs Industry Trends Table 2. Sphingosine-1-Receptor Modulators Drugs Industry Drivers Table 3. Sphingosine-1-Receptor Modulators Drugs Industry Opportunities and Challenges Table 4. Sphingosine-1-Receptor Modulators Drugs Industry Restraints Table 5. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sphingosine-1-Receptor Modulators Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers Table 9. Global Sphingosine-1-Receptor Modulators Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sphingosine-1-Receptor Modulators Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sphingosine-1-Receptor Modulators Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sphingosine-1-Receptor Modulators Drugs Manufacturers, Product Type & Application Table 13. Global Sphingosine-1-Receptor Modulators Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sphingosine-1-Receptor Modulators Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Siponimod Table 17. Major Manufacturers of Fingolimod Table 18. Major Manufacturers of Ozanimod Table 19. Major Manufacturers of Other Table 20. Global Sphingosine-1-Receptor Modulators Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2021-2026) & (K Units) Table 22. Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2027-2032) & (K Units) Table 23. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2021-2026) Table 24. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2027-2032) Table 25. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2021-2026) & (K Units) Table 27. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2027-2032) & (K Units) Table 28. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Other Table 33. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2021-2026) & (K Units) Table 35. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2027-2032) & (K Units) Table 36. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2021-2026) Table 37. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2027-2032) Table 38. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2021-2026) & (K Units) Table 40. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2027-2032) & (K Units) Table 41. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2021-2026) Table 46. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2026) & (K Units) Table 50. North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2027-2032) & (K Units) Table 51. Europe Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2026) & (K Units) Table 53. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Sphingosine-1-Receptor Modulators Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2027-2032) Table 65. Sun Pharma Company Information Table 66. Sun Pharma Business Overview Table 67. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 69. Sun Pharma Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Novartis Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 79. Novartis Recent Development Table 80. Idorsia Company Information Table 81. Idorsia Business Overview Table 82. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Idorsia Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 84. Idorsia Recent Development Table 85. HEC Pharm Co. Limited Company Information Table 86. HEC Pharm Co. Limited Business Overview Table 87. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 89. HEC Pharm Co. Limited Recent Development Table 90. Bristol-Myers Squibb Company Information Table 91. Bristol-Myers Squibb Business Overview Table 92. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 94. Bristol-Myers Squibb Recent Development Table 95. Biocon Company Information Table 96. Biocon Business Overview Table 97. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Biocon Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 99. Biocon Recent Development Table 100. Arena Pharmaceuticals Company Information Table 101. Arena Pharmaceuticals Business Overview Table 102. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Portfolio Table 104. Arena Pharmaceuticals Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Sphingosine-1-Receptor Modulators Drugs Distributors List Table 108. Sphingosine-1-Receptor Modulators Drugs Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Sphingosine-1-Receptor Modulators Drugs Product Image Figure 2. Global Sphingosine-1-Receptor Modulators Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sphingosine-1-Receptor Modulators Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Sphingosine-1-Receptor Modulators Drugs Sales (2021-2032) & (K Units) Figure 5. Global Sphingosine-1-Receptor Modulators Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sphingosine-1-Receptor Modulators Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Siponimod Image Figure 9. Fingolimod Image Figure 10. Ozanimod Image Figure 11. Other Image Figure 12. Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2021-2032) Figure 41. China Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Sphingosine-1-Receptor Modulators Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Sphingosine-1-Receptor Modulators Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Sphingosine-1-Receptor Modulators Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Sphingosine-1-Receptor Modulators Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Siponimod
  • Fingolimod
  • Ozanimod
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Sun Pharma
  • Johnson & Johnson
  • Novartis
  • Idorsia
  • HEC Pharm Co. Limited
  • Bristol-Myers Squibb
  • Biocon
  • Arena Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sphingosine-1-Receptor Modulators Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sphingosine-1-Receptor Modulators Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sphingosine-1-Receptor Modulators Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sphingosine-1-Receptor Modulators Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sphingosine-1-Receptor Modulators Drugs Market Dynamics
  1. 2.1 Sphingosine-1-Receptor Modulators Drugs Industry Trends
  2. 2.2 Sphingosine-1-Receptor Modulators Drugs Industry Drivers
  3. 2.3 Sphingosine-1-Receptor Modulators Drugs Industry Opportunities and Challenges
  4. 2.4 Sphingosine-1-Receptor Modulators Drugs Industry Restraints
3 Sphingosine-1-Receptor Modulators Drugs Market by Manufacturers
  1. 3.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sphingosine-1-Receptor Modulators Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sphingosine-1-Receptor Modulators Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sphingosine-1-Receptor Modulators Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sphingosine-1-Receptor Modulators Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Sphingosine-1-Receptor Modulators Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sphingosine-1-Receptor Modulators Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sphingosine-1-Receptor Modulators Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sphingosine-1-Receptor Modulators Drugs Tier 1, Tier 2, and Tier 3
4 Sphingosine-1-Receptor Modulators Drugs Market by Type
  1. 4.1 Sphingosine-1-Receptor Modulators Drugs Type Introduction
  2. 4.1.1 Siponimod
  3. 4.1.2 Fingolimod
  4. 4.1.3 Ozanimod
  5. 4.1.4 Other
  6. 4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type
  7. 4.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type
  11. 4.3.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2021-2032)
5 Sphingosine-1-Receptor Modulators Drugs Market by Application
  1. 5.1 Sphingosine-1-Receptor Modulators Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application
  6. 5.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application
  10. 5.3.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2021-2032)
6 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region
  1. 6.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region
  1. 7.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region
  2. 7.1.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032)
  8. 7.2.2 North America Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharma
  2. 8.1.1 Sun Pharma Company Information
  3. 8.1.2 Sun Pharma Business Overview
  4. 8.1.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  6. 8.1.5 Sun Pharma Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Idorsia
  20. 8.4.1 Idorsia Company Information
  21. 8.4.2 Idorsia Business Overview
  22. 8.4.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Idorsia Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  24. 8.4.5 Idorsia Recent Developments
  25. 8.5 HEC Pharm Co. Limited
  26. 8.5.1 HEC Pharm Co. Limited Company Information
  27. 8.5.2 HEC Pharm Co. Limited Business Overview
  28. 8.5.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  30. 8.5.5 HEC Pharm Co. Limited Recent Developments
  31. 8.6 Bristol-Myers Squibb
  32. 8.6.1 Bristol-Myers Squibb Company Information
  33. 8.6.2 Bristol-Myers Squibb Business Overview
  34. 8.6.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  36. 8.6.5 Bristol-Myers Squibb Recent Developments
  37. 8.7 Biocon
  38. 8.7.1 Biocon Company Information
  39. 8.7.2 Biocon Business Overview
  40. 8.7.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biocon Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  42. 8.7.5 Biocon Recent Developments
  43. 8.8 Arena Pharmaceuticals
  44. 8.8.1 Arena Pharmaceuticals Company Information
  45. 8.8.2 Arena Pharmaceuticals Business Overview
  46. 8.8.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Portfolio
  48. 8.8.5 Arena Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sphingosine-1-Receptor Modulators Drugs Value Chain Analysis
  2. 9.1.1 Sphingosine-1-Receptor Modulators Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sphingosine-1-Receptor Modulators Drugs Production Mode & Process
  6. 9.2 Sphingosine-1-Receptor Modulators Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sphingosine-1-Receptor Modulators Drugs Distributors
  9. 9.2.3 Sphingosine-1-Receptor Modulators Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst